Cerebrospinal Fluid Tissue Transglutaminase as a Biochemical Marker for Alzheimer's Disease
Authors:
- Raphael M. BonelliRBRaphael M. Bonelli
- Andreas AschoffbAAAndreas Aschoffb
- Gerald NiederwieseraGNGerald Niederwiesera
- Clemens HeubergercCHClemens Heubergerc
- Gustaf JirikowskibGJGustaf Jirikowskib
- 1 October 2002
- journal article
- research article
- Published by Elsevier in Neurobiology of Disease
- Vol. 11 (1) , 106-110
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Tissue Transglutaminase Selectively Modifies Proteins Associated with Truncated Mutant Huntingtin in Intact CellsNeurobiology of Disease, 2001
- Tissue Transglutaminase Does Not Contribute to the Formation of Mutant Huntingtin AggregatesJournal of Cell Biology, 2001
- Evaluation of CSF-tau and CSF-Aβ42 as Diagnostic Markers for Alzheimer Disease in Clinical PracticeArchives of Neurology, 2001
- Plasticity and stabilization of neuromuscular and CNS synapses: interactions between thrombin protease signaling pathways and tissue transglutaminase2001
- DNA damage and apoptosis in Alzheimer's disease: colocalization with c- Jun immunoreactivity, relationship to brain area, and effect of postmortem delayThe Journal of Neuroscience, 1996
- A potential role for apoptosis in neurodegeneration and Alzheimer's diseaseMolecular Neurobiology, 1995
- Transglutaminase Catalyzes the Formation of Sodium Dodecyl Sulfate‐Insoluble, Alz‐50‐Reactive Polymers of τJournal of Neurochemistry, 1993
- Rapid and transient alterations in transglutaminase activity in rat superior cervical ganglia following denervation or axotomyNeuroscience Research, 1993
- Cell cycle kinetics, tissue transglutaminase and programmed cell death (apoptosis)FEBS Letters, 1992
- Alzheimer's disease: Tau proteins, the promoting factors of microtubule assembly, are major components of paired helical filamentsJournal of the Neurological Sciences, 1986